Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[apocrine nevus
4
nevus study
4
study cases]
4
[apocrine
1
study
1
cases]
1
Similar Publications
[Efficacy of wound exclusion combined with silicone tube bicanalicular intubation in the treatment of pigmented nevi of the lacrimal punctum].
Zhonghua Yan Ke Za Zhi
December 2024
Department of Ophthalmology, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou310004, China.
Article Synopsis
- A total of 15 patients (5 men, 10 women) underwent the procedure, which involved excising the nevus while placing a silicone tube to support the area; surgeries lasted about 22 minutes on average.
- Post-surgery results showed no recurrence of nevi, healthy healing with normal eyelid appearance, and no significant complications observed during follow-up periods ranging from 6 months to 2 years.
Article Synopsis
- Syringocystadenoma papilliferum is a rare benign tumor linked to sweat glands, often appearing as a slow-growing skin lesion.
- A 30-year-old woman had a 10-year history of an asymptomatic scalp nodule that developed after head trauma, which was examined and found to be 3 mm in size with specific features.
- A biopsy confirmed the diagnosis, and the patient successfully had the tumor removed through surgery.
Intradermal Syringocystadenoma Papilliferum on the Popliteal Fossa: A Rare Dermal Variant in an Atypical Location.
R I Med J (2013)
July 2024
Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Article Synopsis
- Syringocystadenoma papilliferum (SCAP) is a harmless lump usually found on the scalp and face, often starting in childhood.
- A 55-year-old man had a rare SCAP lump on the back of his knee that didn't hurt and was small in size.
- The doctors took a sample of the lump and decided to remove it, as this type of SCAP is very uncommon in that area of the body.
Syringocystadenocarcinoma papilliferum: a systematic review of clinical characteristics, reappraisal of associations, diagnostic pitfalls and management challenges.
Arch Dermatol Res
June 2024
Department of Dermatology, SUNY Downstate, 450 Clarkson Ave, Brooklyn, NY, USA.
Article Synopsis
- Syringocystadenocarcinoma papilliferum (SCACP) is a rare and aggressive cancer originating from skin appendage glands, often linked to previous skin conditions like syringocystadenoma papilliferum or nevus sebaceus.
- A systematic review analyzed 78 case studies from 1980 to 2024, focusing on clinical features, diagnosis, treatments, and outcomes of SCACP, which commonly affects older adults and presents as ulcerated nodules on the scalp.
- The study emphasizes the importance of surgical treatment, particularly Mohs micrographic surgery, and suggests more research into standardized treatment protocols and targeted therapies to better improve patient outcomes and understanding of its relationships with other skin conditions.
Spitz naevus with syringomatous eccrine ductal hyperplasia and ROS1 fusion.
Pathology
October 2024
Consultant Dermatologist, United Lincolnshire Hospitals NHS Trust, Lincoln County Hospital, Lincoln, England, UK.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!